{
  "id": "602598301cb411341a0000b0",
  "type": "factoid",
  "question": "What does csDMARD stand for?",
  "ideal_answer": "csDMARDS are conventional synthetic disease-modifying antirheumatic drugs.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/30629813"
  ],
  "snippets": [
    {
      "text": "To determine whether intensive combinations of conventional synthetic disease-modifying antirheumatic drugs (csDMARDS) achieve similar clinical benefits more cheaply than high-cost biologics such as tumor necrosis factor inhibitors (TNFi) in patients with active rheumatoid arthritis (RA) whose illness has failed to respond to methotrexate and another DMARD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30629813",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "conventional synthetic disease-modifying antirheumatic drug"
}